{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:51:32Z","timestamp":1785336692283,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,3,23]],"date-time":"2013-03-23T00:00:00Z","timestamp":1363996800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Aberrant chromatin structure in cancer cells results from altered proteins involved in its packaging. Heterochromatin protein 1 gamma (HP1\u03b3) is a non-histone heterochromatic protein that functions to maintain chromatin stability and is important in embryonic development. Given an interest in the role developmental genes play in cancer, we investigated HP1\u03b3 expression in prostate cancer (PCa) and its prognostic associations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Tissue microarrays consisting of benign (N = 96), localized cancer (N = 146), metastatic PCa (N = 44), and HGPIN (N = 50) were immunoflourescently stained for HP1\u03b3 and Ki-67. Using a novel, automated quantitative imaging system, VECTRA\u2122, epithelial staining in both the nucleus and cytoplasm was quantified and compared against clinicopathologic variables.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>HP1\u03b3 is significantly elevated in HGPIN (80%), localized PCa (76%), and metastatic PCa (98%) compared to benign tissues from both the nuclear and cytoplasmic compartments (<jats:italic>P<\/jats:italic>&lt; 0.0001). Increased nuclear and total HP1\u03b3 expression was associated with Gleason score (<jats:italic>P<\/jats:italic>= 0.02 and<jats:italic>P<\/jats:italic>= 0.04 respectively). Given known binding to the C-terminus of Ki-67, a co-expression analysis was performed that revealed a correlation between nuclear and cytoplasmic HP1\u03b3 and Ki-67 (Pearson Coefficient 0.321 and 0.562 respectively,<jats:italic>P<\/jats:italic>&lt; 0.0001). Cox survival analysis demonstrated that cytoplasmic HP1\u03b3 expression was an independent prognostic marker and out-performed pathological Gleason score for predicting PSA-recurrence after radical prostatectomy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In this first detailed analysis of HP1\u03b3 expression in cancer, VECTRA\u2122 demonstrates compartmentalized and total HP1\u03b3 protein expression is increased in PCa and that expression correlates with clinical outcomes better than Gleason score. Given the critical role HP1\u03b3 plays in chromatin organization and gene expression, it represents a novel prognostic and therapeutic target.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1471-2407-13-148","type":"journal-article","created":{"date-parts":[[2013,3,23]],"date-time":"2013-03-23T23:14:03Z","timestamp":1364080443000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["HP1\u03b3 expression is elevated in prostate cancer and is superior to Gleason score as a predictor of biochemical recurrence after radical prostatectomy"],"prefix":"10.1186","volume":"13","author":[{"given":"Jon","family":"Slezak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jarrard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,23]]},"reference":[{"issue":"1","key":"3773_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 2012, 62 (1): 10-29. 10.3322\/caac.20138.","journal-title":"CA Cancer J Clin"},{"issue":"57","key":"3773_CR2","doi-asserted-by":"publisher","first-page":"7180","DOI":"10.1038\/onc.2008.327","volume":"27","author":"EM Schaeffer","year":"2008","unstructured":"Schaeffer EM, Marchionni L, Huang Z, Simons B, Blackman A, Yu W, Parmigiani G, Berman DM: Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer. Oncogene. 2008, 27 (57): 7180-7191. 10.1038\/onc.2008.327.","journal-title":"Oncogene"},{"issue":"1\u20132","key":"3773_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.mrfmmm.2008.09.007","volume":"647","author":"GK Dialynas","year":"2008","unstructured":"Dialynas GK, Vitalini MW, Wallrath LL: Linking Heterochromatin Protein 1 (HP1) to cancer progression. Mutat Res. 2008, 647 (1\u20132): 13-20.","journal-title":"Mutat Res"},{"issue":"6","key":"3773_CR4","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1016\/j.juro.2008.01.091","volume":"179","author":"E Shapiro","year":"2008","unstructured":"Shapiro E, Huang H, Ruoff R, Lee P, Tanese N, Logan SK: The heterochromatin protein 1 family is regulated in prostate development and cancer. J Urol. 2008, 179 (6): 2435-2439. 10.1016\/j.juro.2008.01.091.","journal-title":"J Urol"},{"issue":"1","key":"3773_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2353\/ajpath.2009.080148","volume":"174","author":"M Takanashi","year":"2009","unstructured":"Takanashi M, Oikawa K, Fujita K, Kudo M, Kinoshita M, Kuroda M: Heterochromatin protein 1gamma epigenetically regulates cell differentiation and exhibits potential as a therapeutic target for various types of cancers. Am J Pathol. 2009, 174 (1): 309-316. 10.2353\/ajpath.2009.080148.","journal-title":"Am J Pathol"},{"issue":"11","key":"3773_CR6","doi-asserted-by":"publisher","first-page":"e15507","DOI":"10.1371\/journal.pone.0015507","volume":"5","author":"M Caillier","year":"2010","unstructured":"Caillier M, Th\u00e9not S, Tribollet V, Birot AM, Samarut J, Mey A: Role of the epigenetic regulator HP1\u03b3 in the control of embryonic stem cell properties. PLoS One. 2010, 5 (11): e15507-10.1371\/journal.pone.0015507.","journal-title":"PLoS One"},{"issue":"7","key":"3773_CR7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/gb-2006-7-7-228","volume":"7","author":"G Lomberk","year":"2006","unstructured":"Lomberk G, Wallrath L, Urrutia R: The Heterochromatin Protein 1 family. Genome Biol. 2006, 7 (7): 228-10.1186\/gb-2006-7-7-228.","journal-title":"Genome Biol"},{"issue":"17","key":"3773_CR8","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1101\/gad.17325211","volume":"25","author":"S Canudas","year":"2011","unstructured":"Canudas S, Houghtaling BR, Bhanot M, Sasa G, Savage SA, Bertuch AA, Smith S: A role for heterochromatin protein 1\u03b3 at human telomeres. Genes Dev. 2011, 25 (17): 1807-1819. 10.1101\/gad.17325211.","journal-title":"Genes Dev"},{"issue":"3","key":"3773_CR9","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1128\/MCB.01639-06","volume":"27","author":"R Zhang","year":"2007","unstructured":"Zhang R, Liu ST, Chen W, Bonner M, Pehrson J, Yen TJ, Adams PD: HP1 proteins are essential for a dynamic nuclear response that rescues the function of perturbed heterochromatin in primary human cells. Mol Cell Biol. 2007, 27 (3): 949-962. 10.1128\/MCB.01639-06.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"3773_CR10","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1083\/jcb.200810035","volume":"185","author":"MS Luijsterburg","year":"2009","unstructured":"Luijsterburg MS, Dinant C, Lans H, Stap J, Wiernasz E, Lagerwerf S, Warmerdam DO, Lindh M, Brink MC, Dobrucki JW: Heterochromatin protein 1 is recruited to various types of DNA damage. J Cell Biol. 2009, 185 (4): 577-586. 10.1083\/jcb.200810035.","journal-title":"J Cell Biol"},{"issue":"13","key":"3773_CR11","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.1158\/1078-0432.CCR-10-0763","volume":"17","author":"M Tanaka","year":"2011","unstructured":"Tanaka M, Chang P, Li Y, Li D, Overman M, Maru DM, Sethi S, Phillips J, Bland GL, Abbruzzese JL: Association of CHFR promoter methylation with disease recurrence in locally advanced colon cancer. Clin Cancer Res. 2011, 17 (13): 4531-4540. 10.1158\/1078-0432.CCR-10-0763.","journal-title":"Clin Cancer Res"},{"issue":"13","key":"3773_CR12","first-page":"3359","volume":"60","author":"DA Kirschmann","year":"2000","unstructured":"Kirschmann DA, Lininger RA, Gardner LM, Seftor EA, Odero VA, Ainsztein AM, Earnshaw WC, Wallrath LL, Hendrix MJ: Down-regulation of HP1Hsalpha expression is associated with the metastatic phenotype in breast cancer. Cancer Res. 2000, 60 (13): 3359-3363.","journal-title":"Cancer Res"},{"issue":"2","key":"3773_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/path.1016","volume":"196","author":"T Scholzen","year":"2002","unstructured":"Scholzen T, Endl E, Wohlenberg C, van der Sar S, Cowell IG, Gerdes J, Singh PB: The Ki-67 protein interacts with members of the heterochromatin protein 1 (HP1) family: a potential role in the regulation of higher-order chromatin structure. J Pathol. 2002, 196 (2): 135-144. 10.1002\/path.1016.","journal-title":"J Pathol"},{"key":"3773_CR14","volume-title":"Hum Pathol","author":"W Huang","year":"2012","unstructured":"Huang W, Hennrick K, Sally Drew BS M: A colorful future of quantitative pathology: validation of Vectra technology using chromogenic multiplexed immunohistochemistry and prostate tissue microarrays. Hum Pathol. 2012, in press"},{"issue":"5570","key":"3773_CR15","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1126\/science.1069861","volume":"296","author":"H Ogawa","year":"2002","unstructured":"Ogawa H, Ishiguro K, Gaubatz S, Livingston DM, Nakatani Y: A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells. Science. 2002, 296 (5570): 1132-1136. 10.1126\/science.1069861.","journal-title":"Science"},{"issue":"1","key":"3773_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ijc.2910310104","volume":"31","author":"J Gerdes","year":"1983","unstructured":"Gerdes J, Schwab U, Lemke H, Stein H: Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer. 1983, 31 (1): 13-20. 10.1002\/ijc.2910310104.","journal-title":"Int J Cancer"},{"issue":"4","key":"3773_CR17","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.4049\/jimmunol.133.4.1710","volume":"133","author":"J Gerdes","year":"1984","unstructured":"Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984, 133 (4): 1710-1715.","journal-title":"J Immunol"},{"issue":"2","key":"3773_CR18","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.juro.2006.09.025","volume":"177","author":"FK Chun","year":"2007","unstructured":"Chun FK, Briganti A, Graefen M, Porter C, Montorsi F, Haese A, Scattoni V, Borden L, Steuber T, Salonia A: Development and external validation of an extended repeat biopsy nomogram. J Urol. 2007, 177 (2): 510-515. 10.1016\/j.juro.2006.09.025.","journal-title":"J Urol"},{"issue":"16","key":"3773_CR19","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1002\/pros.20848","volume":"68","author":"RW Veltri","year":"2008","unstructured":"Veltri RW, Isharwal S, Miller MC, Epstein JI, Mangold LA, Humphreys E, Partin AW: Long-term assessment of prostate cancer progression free survival: evaluation of pathological parameters, nuclear shape and molecular biomarkers of pathogenesis. Prostate. 2008, 68 (16): 1806-1815. 10.1002\/pros.20848.","journal-title":"Prostate"},{"issue":"3","key":"3773_CR20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S1470-2045(10)70295-3","volume":"12","author":"J Cuzick","year":"2011","unstructured":"Cuzick J, Swanson GP, Fisher G, Brothman AR, Berney DM, Reid JE, Mesher D, Speights VO, Stankiewicz E, Foster CS: Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study. Lancet Oncol. 2011, 12 (3): 245-255. 10.1016\/S1470-2045(10)70295-3.","journal-title":"Lancet Oncol"},{"issue":"8","key":"3773_CR21","doi-asserted-by":"publisher","first-page":"R317","DOI":"10.1016\/S0960-9822(03)00236-7","volume":"13","author":"RT Kamakaka","year":"2003","unstructured":"Kamakaka RT: Heterochromatin: proteins in flux lead to stable repression. Curr Biol. 2003, 13 (8): R317-319. 10.1016\/S0960-9822(03)00236-7.","journal-title":"Curr Biol"},{"issue":"4","key":"3773_CR22","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ncb1383","volume":"8","author":"G Lomberk","year":"2006","unstructured":"Lomberk G, Bensi D, Fernandez-Zapico ME, Urrutia R: Evidence for the existence of an HP1-mediated subcode within the histone code. Nat Cell Biol. 2006, 8 (4): 407-415. 10.1038\/ncb1383.","journal-title":"Nat Cell Biol"},{"issue":"3\u20134","key":"3773_CR23","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000056789","volume":"90","author":"E Minc","year":"2000","unstructured":"Minc E, Courvalin JC, Buendia B: HP1gamma associates with euchromatin and heterochromatin in mammalian nuclei and chromosomes. Cytogenet Cell Genet. 2000, 90 (3\u20134): 279-284.","journal-title":"Cytogenet Cell Genet"},{"issue":"3","key":"3773_CR24","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/S0022-5347(01)65703-3","volume":"156","author":"MC Bettencourt","year":"1996","unstructured":"Bettencourt MC, Bauer JJ, Sesterhenn IA, Mostofi FK, McLeod DG, Moul JW: Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy. J Urol. 1996, 156 (3): 1064-1068. 10.1016\/S0022-5347(01)65703-3.","journal-title":"J Urol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-148.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-13-148\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-148","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-148.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T13:36:15Z","timestamp":1688132175000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-13-148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,23]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3773"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-13-148","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,23]]},"assertion":[{"value":"27 September 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"148"}}